Christoph H Westphal - Net Worth and Insider Trading

Christoph H Westphal Net Worth

The estimated net worth of Christoph H Westphal is at least $30 Million dollars as of 2024-04-26. Christoph H Westphal is the 10% Owner of TScan Therapeutics Inc and owns about 2,315,423 shares of TScan Therapeutics Inc (TCRX) stock worth over $17 Million. Christoph H Westphal is the Executive Chairman of Verastem Inc and owns about 956,310 shares of Verastem Inc (VSTM) stock worth over $9 Million. Christoph H Westphal is also the Director of Momenta Pharmaceuticals Inc and owns about 76,648 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $4 Million. Besides these, Christoph H Westphal also holds Millendo Therapeutics Inc (MLND) , Salarius Pharmaceuticals Inc (SLRX) . Details can be seen in Christoph H Westphal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christoph H Westphal has not made any transactions after 2021-07-20 and currently still holds the listed stock(s).

Transaction Summary of Christoph H Westphal

To

Christoph H Westphal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christoph H Westphal owns 7 companies in total, including Salarius Pharmaceuticals Inc () , Verastem Inc () , and Millendo Therapeutics Inc () among others .

Click here to see the complete history of Christoph H Westphal’s form 4 insider trades.

Insider Ownership Summary of Christoph H Westphal

Ticker Comapny Transaction Date Type of Owner
Salarius Pharmaceuticals Inc 2018-10-16 10 percent owner
Verastem Inc 2014-12-19 director & 10 percent owner & President & Chief Exec Officer
Millendo Therapeutics Inc 2014-03-07 director & 10 percent owner
Momenta Pharmaceuticals Inc 2005-05-26 director
Alnylam Pharmaceuticals Inc 2004-05-27 director & 10 percent owner
Tempest Therapeutics Inc 2013-06-07 director & 10 percent owner
TScan Therapeutics Inc 2021-07-20 director & 10 percent owner

Christoph H Westphal Latest Holdings Summary

Christoph H Westphal currently owns a total of 5 stocks. Among these stocks, Christoph H Westphal owns 2,315,423 shares of TScan Therapeutics Inc (TCRX) as of July 20, 2021, with a value of $17 Million and a weighting of 56.76%. Christoph H Westphal owns 956,310 shares of Verastem Inc (VSTM) as of December 19, 2014, with a value of $9 Million and a weighting of 29.63%. Christoph H Westphal also owns 76,648 shares of Momenta Pharmaceuticals Inc (MNTA) as of June 25, 2004, with a value of $4 Million and a weighting of 13.53%. The other 2 stocks Millendo Therapeutics Inc (MLND) , Salarius Pharmaceuticals Inc (SLRX) have a combined weighting of 0.08% among all his current holdings.

Latest Holdings of Christoph H Westphal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TCRX TScan Therapeutics Inc 2021-07-20 2,315,423 7.29 16,879,434
VSTM Verastem Inc 2014-12-19 956,310 9.22 8,812,397
MNTA Momenta Pharmaceuticals Inc 2004-06-25 76,648 52.48 4,022,487
MLND Millendo Therapeutics Inc 2014-03-07 20,122 1.06 21,329
SLRX Salarius Pharmaceuticals Inc 2018-10-16 6,306 0.50 3,147

Holding Weightings of Christoph H Westphal


Christoph H Westphal Form 4 Trading Tracker

According to the SEC Form 4 filings, Christoph H Westphal has made a total of 1 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TScan Therapeutics Inc is the acquisition of 133,333 shares on July 20, 2021, which cost Christoph H Westphal around $2 Million.

According to the SEC Form 4 filings, Christoph H Westphal has made a total of 0 transactions in Verastem Inc (VSTM) over the past 5 years. The most-recent trade in Verastem Inc is the acquisition of 1,500 shares on December 19, 2014, which cost Christoph H Westphal around $12,750.

According to the SEC Form 4 filings, Christoph H Westphal has made a total of 0 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years. The most-recent trade in Momenta Pharmaceuticals Inc is the acquisition of 160,000 shares on June 25, 2004, which cost Christoph H Westphal around $1 Million.

More details on Christoph H Westphal's insider transactions can be found in the Insider Trading History of Christoph H Westphal table.

Insider Trading History of Christoph H Westphal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christoph H Westphal Trading Performance

GuruFocus tracks the stock performance after each of Christoph H Westphal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christoph H Westphal is -6.98%. GuruFocus also compares Christoph H Westphal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christoph H Westphal within 3 months outperforms 19 times out of 76 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christoph H Westphal's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christoph H Westphal

Average Return

-30.89%

Average return per transaction

Outperforming Transactions

13%

10 out of 76 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.56 -6.98 -19.96 -30.89 -41 -56.53
Relative Return to S&P 500(%) -0.98 -7.73 -22.85 -40.66 -52.53 -66.87

Christoph H Westphal Ownership Network

Ownership Network List of Christoph H Westphal

No Data

Ownership Network Relation of Christoph H Westphal


Christoph H Westphal Owned Company Details

What does Salarius Pharmaceuticals Inc do?

Who are the key executives at Salarius Pharmaceuticals Inc?

Christoph H Westphal is the 10 percent owner of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Chief Financial Officer Scott Jordan .

Salarius Pharmaceuticals Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Salarius Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Salarius Pharmaceuticals Inc Insider Transactions

No Available Data

Christoph H Westphal Mailing Address

Above is the net worth, insider trading, and ownership report for Christoph H Westphal. You might contact Christoph H Westphal via mailing address: C/o Alnylam Pharmaceuticals, Inc, 300 Third Street, Cambridge Ma 02142.

Discussions on Christoph H Westphal

No discussions yet.